Skip to content

Diagnosis and Treatment of Secondary Dacryocystitis

Diagnosis and Treatment of Secondary Dacryocystitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120083
Enrollment
Unknown
Registered
2026-03-09
Start date
2026-03-15
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Secondary dacryocystitis

Interventions

Nasal lacrimal sac anastomosis group:None

Sponsors

Tianjin Medical University Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria for secondary dacryocystitis, including medical history (such as trauma, surgery, tumors, etc.), symptoms (such as swelling, pain, tear overflow, purulent discharge, etc. in the lacrimal sac area), and signs (such as tenderness in the lacrimal sac area, skin fistula, large lacrimal cyst, etc.); 2. Age >= 18 years old; 3. Voluntarily participate in this study and sign an informed consent form; 4. Can cooperate in completing various examinations and follow-up during the research process.

Exclusion criteria

Exclusion criteria: 1. Combining other serious eye diseases (such as glaucoma, retinal detachment, etc.) may affect the diagnosis and treatment evaluation of secondary dacryocystitis. 2. The combination of severe systemic diseases (such as heart failure, severe liver and kidney dysfunction, etc.) may affect the safety and treatment tolerance of patients. 3. Pregnant or lactating women, due to their unique physiological conditions, may affect the selection of treatment plans and medication use. 4. Refusal to participate in this study or inability to cooperate in completing various examinations and follow-up during the research process. 5. Refusal to participate in this study or inability to cooperate in completing various examinations and follow-up during the research process.

Design outcomes

Primary

MeasureTime frame
Surgical efficacy;

Secondary

MeasureTime frame
diagnostic accuracy;

Countries

China

Contacts

Public ContactZhao Liang

Tianjin Medical University Eye Hospital

576310500@qq.com+86 136 5206 0511

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026